1-Boc-4-ethynyl-4-hydroxypiperidine - CAS 275387-83-2
Catalog: |
BB061868 |
Product Name: |
1-Boc-4-ethynyl-4-hydroxypiperidine |
CAS: |
275387-83-2 |
Synonyms: |
tert-butyl 4-ethynyl-4-hydroxypiperidine-1-carboxylate; 1-Boc-4-ethynyl-4-hydroxypiperidine; 4-Ethynyl-1-tert-butoxycarbonylpiperidin-4-ol; N-Boc-4-hydroxy-4-ethynyl-piperidine; 4-ethynyl-4-hydroxypiperidine-1-carboxylic acid tert-butyl ester |
IUPAC Name: | tert-butyl 4-ethynyl-4-hydroxypiperidine-1-carboxylate |
Molecular Weight: | 225.28 |
Molecular Formula: | C12H19NO3 |
Canonical SMILES: | CC(C)(C)OC(=O)N1CCC(CC1)(C#C)O |
InChI: | InChI=1S/C12H19NO3/c1-5-12(15)6-8-13(9-7-12)10(14)16-11(2,3)4/h1,15H,6-9H2,2-4H3 |
InChI Key: | SHEYWYIIXFHSNB-UHFFFAOYSA-N |
References: | Cheng, Y., et al. PCT Int. Appl., (2020). |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113620944-A | Novel RET inhibitors, pharmaceutical compositions thereof and uses thereof | 20200507 |
CN-113620945-A | RET inhibitor, pharmaceutical composition thereof and application thereof in medicines | 20200507 |
CN-111285874-A | RET inhibitors, pharmaceutical compositions thereof and uses thereof | 20181207 |
WO-2020114494-A1 | Ret inhibitors, pharmaceutical compositions and uses thereof | 20181207 |
AU-2019394519-A1 | RET inhibitors, pharmaceutical compositions and uses thereof | 20181207 |
EP-3891148-A1 | Ret inhibitors, pharmaceutical compositions and uses thereof | 20181207 |
KR-20210100155-A | RET inhibitors, pharmaceutical compositions and uses thereof | 20181207 |
JP-2022510689-A | RET Inhibitors, Pharmaceutical Compositions and Their Use | 20181207 |
TW-202021970-A | New heterocyclic compounds | 20180813 |
US-2020308190-A1 | Heterocyclic compounds as monoacylglycerol lipase inhibitors | 20180813 |
Complexity: | 313 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 225.13649347 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 225.13649347 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 49.8Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.9 |
-
Catalog: BB074488
((1R,3R)-3-Amino-cyclopentyl)-carbamic Acid tert-Butyl Ester
Detail
-
Catalog: BB067784
((1R,2R)-2-(2,3-Dihydrobenzofuran-4-yl)cyclopropyl)methanamine
Detail
-
Catalog: BB069924
((2S,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB055105
((2R,5S,10aS,10bS)-5-Benzyl-8,10b-bis(benzyloxy)-2-methyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)carbamic Acid Benzyl Ester
Detail
-
Catalog: BB072639
((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl Dihydrogen Phosphate
Detail
-
Catalog: BB072640
((2R,3S,4R,5R)-5-(4-(Benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl bis(2-cyanoethyl) Phosphate
Detail
-
Catalog: BB069927
((2R,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate
Detail
-
Catalog: BB075348
((2S,3S,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate, sodium salt
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS